Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Varian Medical System | VAR | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 129.97 | 0.00 | 0.00 | 0.00 | 129.97 | 05:32:50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Varian Medical System Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 11.84B | 91.06M | $ 149.90M | 3.37 | 37.20 | 90.65M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.83M | $ - | 0.00% | 4.00 | 0.50% |
Varian Medical System News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VAR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 125.02 | 130.22 | 125.00 | 128.93 | 714,784 | 4.95 | 3.96% |
| 1 Month | 125.93 | 130.22 | 119.37 | 124.81 | 665,165 | 4.04 | 3.21% |
| 3 Months | 107.38 | 135.46 | 103.92 | 118.45 | 675,435 | 22.59 | 21.04% |
| 6 Months | 127.62 | 140.38 | 103.92 | 120.56 | 638,945 | 2.35 | 1.84% |
| 1 Year | 114.48 | 142.50 | 103.92 | 124.81 | 629,549 | 15.49 | 13.53% |
| 3 Years | 89.33 | 142.50 | 76.94 | 111.25 | 636,076 | 40.64 | 45.49% |
| 5 Years | 87.82 | 142.50 | 71.07 | 100.47 | 659,096 | 42.15 | 48.0% |
Varian Medical System Description
| Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (52%), followed by Europe, the Middle East, and Africa (29%) and Asia-Pacific (20%). |
